In the evolving field of aesthetic treatments, patients increasingly seek non-invasive solutions that deliver natural-looking results without compromising efficacy or comfort. Enter EVERESSE, a groundbreaking monopolar RF device that represents the next evolution in non-invasive technology.
Despite a tough economic environment in 2024, aesthetics consumers continued to spend – and they’re not planning to stop in 2025. According to research from NewBeauty, the majority of consumers plan to maintain the same level of spending on aesthetics treatments; even if they had to reduce their overall spending, they’re much more likely to cut...
Classys, Inc. recently spoke at the 2025 J.P. Morgan Healthcare Conference, highlighting their long-term growth and expansion plans in the U.S. and Europe, including their new partnership with Cartessa to bring EVEREVESSE by Volnewmer to the U.S. market. Below is an excerpt from Classys Details US Expansion and European Launch Plans at JPM2025, as...
Cartessa's launch of EVERESSE, the monopolar RF device created by Classys, was recently covered by MedEsthetics Mag. Below is an excerpt from Cartessa Aesthetics Introduces Classys' Everesse to US Skin Tightening & Rejuvenation Market.
Classys, Inc. and Cartessa Aesthetics' recent partnership announcement was featured in Korea Biomedical Review. Below is an excerpt from Classys and Cartessa Launch Anti-Aging Device in US.
Everesse Monopolar RF technology overcomes shortcomings of legacy devices to effectively and comfortably lift and volumize the skin.
